Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 6 minute read Pharma Industry News Evoke Pharma stock surges 130% as QOL Medical signs definitive $11-per-share acquisition agreement Find out how Evoke Pharma’s $11-per-share acquisition by QOL Medical is reshaping specialty pharma and why investors are applauding this record premium. bySoujanya RaviNovember 4, 2025